ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 153 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,359,000 | -44.6% | 220,000 | -18.5% | 0.34% | -54.0% |
| Q1 2018 | $6,067,000 | -40.5% | 270,000 | -20.3% | 0.75% | -45.8% |
| Q4 2017 | $10,204,000 | +1119.1% | 338,882 | +1029.6% | 1.38% | +1049.2% |
| Q2 2017 | $837,000 | -72.9% | 30,000 | -66.7% | 0.12% | -75.5% |
| Q1 2017 | $3,094,000 | +53.2% | 90,000 | +28.6% | 0.49% | +26.6% |
| Q4 2016 | $2,019,000 | -99.9% | 70,000 | +40.0% | 0.39% | +53.0% |
| Q3 2016 | $1,590,500,000 | +97897.5% | 50,000 | 0.0% | 0.25% | -12.2% |
| Q2 2016 | $1,623,000 | +16.1% | 50,000 | 0.0% | 0.29% | +3.6% |
| Q1 2016 | $1,398,000 | -67.3% | 50,000 | -58.3% | 0.28% | -57.0% |
| Q4 2015 | $4,278,000 | -34.0% | 120,000 | -38.8% | 0.65% | -37.4% |
| Q3 2015 | $6,482,000 | -19.0% | 196,000 | +2.6% | 1.03% | +7.5% |
| Q2 2015 | $7,999,000 | +43.5% | 191,000 | +11.7% | 0.96% | +2.2% |
| Q1 2015 | $5,573,000 | +6.4% | 171,000 | +3.6% | 0.94% | -38.1% |
| Q4 2014 | $5,239,000 | -3.4% | 165,000 | -24.7% | 1.52% | -4.3% |
| Q3 2014 | $5,422,000 | +4.3% | 219,000 | -4.8% | 1.59% | +3.0% |
| Q2 2014 | $5,196,000 | +20.7% | 230,000 | +30.0% | 1.54% | +19.3% |
| Q1 2014 | $4,304,000 | +102.6% | 176,883 | +108.1% | 1.29% | +55.5% |
| Q4 2013 | $2,124,000 | – | 85,000 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |